Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib
CompletedOBSERVATIONAL
Enrollment
111
Participants
Timeline
Start Date
January 31, 2013
Primary Completion Date
January 31, 2014
Study Completion Date
January 31, 2014
Conditions
Breast Neoplasm
Trial Locations (11)
Unknown
Barcelona
Córdoba
Girona
Jaén
Madrid
Pamplona
Salamanca
Santiago de Compostela
Seville
Valencia
Zaragoza
All Listed Sponsors
lead
MedSIR
OTHER
NCT02056080 - Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib | Biotech Hunter | Biotech Hunter